Salgomed is a company that offers a platform for precision medicine that can be used to identify cancer drug targets and provide the clinical validation of candidate drugs. Its technology is based on machine learning, disease-specific molecular networks, high-throughput screening on patient’s cells, and search algorithms to discover effective drug combinations.